Table 2. Significantly upregulated lipid molecular species between the bone metastatic MDAPCa2b cells and the non-malignant RC77N-E cells.
| Compound LC MS/MS ID | LMID | Common Name | Exact Neutral Monoisotopic Mass | Maximum Fold increase | Highest Mean Cell Line | Lowest Mean Cell Line | P value |
|---|---|---|---|---|---|---|---|
| 16.5_902.8157m/z | 902.8157 | 2.27 | MDAPCa2b | RC77N-E | 1.43E-06 | ||
| 16.15_858.7656 | LMGP03010100 | TG(16:0/18:1/18:1) | 876.8000 | 1.55 | MDAPCa2b | RC77N-E | 4.47E-06 |
| 6.31_782.5669m/z | 782.5669 | 18.0 | MDAPCa2b | RC77N-E | 4.86E-06 | ||
| 8.77_717.5328n | 717.5412 | 6.97 | MDAPCa2b | RC77N-E | 6.7E-06 | ||
| 6.42_807.5764n | 807.5764 | 12.7 | MDAPCa2b | RC77N-E | 7.21E-06 | ||
| 8.13_759.5775n | LMGP01010005 | PC(16:0/18:1) | 760.5855 | 2.84 | MDAPCa2b | RC77N-E | 1.16E-11 |
| 16.40_912.8124n | 912.8124 | 3.32 | MDAPCa2b | RC77N-E | 1.99E-5 | ||
| 16.41_886.7921n | LMGL03010238 | TG(16:0/18:0/20:2) | 886.7921 | 2.77 | MDAPCa2b | RC77N-E | 2.37 E-5 |
| 5.79_725.5567m/z | 725.5567 | 4.12 | MDAPCa2b | RC77N-E | 3.85E-5 | ||
| 8.14_1519.1517n | 1519.1517 | 369 | MDAPCa2b | RC77N-E | 5.18E-5 | ||
| 6.45_731.5459n | LMGP01010566 | PC(16:0/16:1) | 731.5459 | 4.77 | MDAPCa2b | RC77N-E | 9.13E-5 |
| 9.04_743.5509n | 743.5509 | 2.62 | MDAPCa2b | RC77N-E | 1.19E-4 | ||
| 16.43_860.7813n | 860.7813 | 1.57 | MDAPCa2b | RC77N-E | 1.2E-4 | ||
| 7.86_734.5698m/z | LMGP1010564 | PC(16:0/16:0) | 733.5622 | 2.67 | MDAPCa2b | RC77N-E | 1.39E-4 |
| 10.84_787.6085n | LMGP1010764 | PC(18:0/18:1) | 787.6085 | 2.11 | MDAPCa2b | RC77N-E | 1.79E-4 |
| 5.79_702.5656n | LMSP03010003 | SM(d18:1/16:0) | 702.5656 | 2.24 | MDAPCa2b | RC77N-E | 2.02E-4 |